Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma

Erzsébet Szabó, Éva Korpos, Enkhjargal Batmunkh, G. Lotz, Ágnes Holczbauer, I. Kovalszky, Ferenc Deák, I. Kiss, Z. Schaff, András Kiss

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The recently described matrilin protein family is part of the extracellular matrix, their pathophysiological role as well as distribution in liver diseases, however, have not yet been studied. Considering that matrilins have been found to play role in cell growth and tissue remodeling, their possible involvement in carcinogenesis has been raised. The main objective of this study was to investigate the changes in matrilin-2 expression which is one of the main components of basement membranes. Thirty-five cases of surgically resected hepatocellular carcinomas, 35 corresponding surrounding liver tissues and 10 normal liver samples were used for the study. In 15 of 35 cases the tumor developed on the basis of cirrhosis. Matrilin-2 protein expression was detected in normal liver around bile ducts, portal blood vessels, while sinusoids were negative by immunohistochemistry. Cirrhotic surrounding tissue showed intensive matrilin-2 staining along the sinusoids. Tumorous neovasculature was found strongly positive by immunohistochemistry. No differences, however, were detected by morphometry regarding the amount of protein expression based on the grade of hepatocellular carcinomas. Real-time RT-PCR did not show significant differences in matrilin-2 mRNA expression between normal, cirrhotic and tumor samples. This suggests posttranslational modification of matrilin-2 manifesting in altered distribution in liver fibrosis. Our data indicate that matrilin-2 is a novel basement membrane component in the liver, which is synthetised during sinusoidal "capillarization" in cirrhosis and in hepatocellular carcinoma. This is the first report to describe the expression and distribution of matrilin-2 in human normal and cirrhotic liver as well as in hepatocellular carcinoma.

Original languageEnglish
Pages (from-to)15-22
Number of pages8
JournalPathology and Oncology Research
Volume14
Issue number1
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Matrilin Proteins
Liver Cirrhosis
Hepatocellular Carcinoma
Liver
Basement Membrane
Fibrosis
Immunohistochemistry
Post Translational Protein Processing
Bile Ducts
Extracellular Matrix
Blood Vessels
Liver Diseases
Real-Time Polymerase Chain Reaction
Neoplasms
Carcinogenesis

Keywords

  • Basement membrane
  • Cirrhosis
  • Extracellular matrix
  • Hepatocellular carcinoma
  • Matrilin-2

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pathology and Forensic Medicine

Cite this

Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma. / Szabó, Erzsébet; Korpos, Éva; Batmunkh, Enkhjargal; Lotz, G.; Holczbauer, Ágnes; Kovalszky, I.; Deák, Ferenc; Kiss, I.; Schaff, Z.; Kiss, András.

In: Pathology and Oncology Research, Vol. 14, No. 1, 03.2008, p. 15-22.

Research output: Contribution to journalArticle

Szabó, Erzsébet ; Korpos, Éva ; Batmunkh, Enkhjargal ; Lotz, G. ; Holczbauer, Ágnes ; Kovalszky, I. ; Deák, Ferenc ; Kiss, I. ; Schaff, Z. ; Kiss, András. / Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma. In: Pathology and Oncology Research. 2008 ; Vol. 14, No. 1. pp. 15-22.
@article{0b7189731df2471b928c568a9fb5abfe,
title = "Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma",
abstract = "The recently described matrilin protein family is part of the extracellular matrix, their pathophysiological role as well as distribution in liver diseases, however, have not yet been studied. Considering that matrilins have been found to play role in cell growth and tissue remodeling, their possible involvement in carcinogenesis has been raised. The main objective of this study was to investigate the changes in matrilin-2 expression which is one of the main components of basement membranes. Thirty-five cases of surgically resected hepatocellular carcinomas, 35 corresponding surrounding liver tissues and 10 normal liver samples were used for the study. In 15 of 35 cases the tumor developed on the basis of cirrhosis. Matrilin-2 protein expression was detected in normal liver around bile ducts, portal blood vessels, while sinusoids were negative by immunohistochemistry. Cirrhotic surrounding tissue showed intensive matrilin-2 staining along the sinusoids. Tumorous neovasculature was found strongly positive by immunohistochemistry. No differences, however, were detected by morphometry regarding the amount of protein expression based on the grade of hepatocellular carcinomas. Real-time RT-PCR did not show significant differences in matrilin-2 mRNA expression between normal, cirrhotic and tumor samples. This suggests posttranslational modification of matrilin-2 manifesting in altered distribution in liver fibrosis. Our data indicate that matrilin-2 is a novel basement membrane component in the liver, which is synthetised during sinusoidal {"}capillarization{"} in cirrhosis and in hepatocellular carcinoma. This is the first report to describe the expression and distribution of matrilin-2 in human normal and cirrhotic liver as well as in hepatocellular carcinoma.",
keywords = "Basement membrane, Cirrhosis, Extracellular matrix, Hepatocellular carcinoma, Matrilin-2",
author = "Erzs{\'e}bet Szab{\'o} and {\'E}va Korpos and Enkhjargal Batmunkh and G. Lotz and {\'A}gnes Holczbauer and I. Kovalszky and Ferenc De{\'a}k and I. Kiss and Z. Schaff and Andr{\'a}s Kiss",
year = "2008",
month = "3",
doi = "10.1007/s12253-008-9005-4",
language = "English",
volume = "14",
pages = "15--22",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma

AU - Szabó, Erzsébet

AU - Korpos, Éva

AU - Batmunkh, Enkhjargal

AU - Lotz, G.

AU - Holczbauer, Ágnes

AU - Kovalszky, I.

AU - Deák, Ferenc

AU - Kiss, I.

AU - Schaff, Z.

AU - Kiss, András

PY - 2008/3

Y1 - 2008/3

N2 - The recently described matrilin protein family is part of the extracellular matrix, their pathophysiological role as well as distribution in liver diseases, however, have not yet been studied. Considering that matrilins have been found to play role in cell growth and tissue remodeling, their possible involvement in carcinogenesis has been raised. The main objective of this study was to investigate the changes in matrilin-2 expression which is one of the main components of basement membranes. Thirty-five cases of surgically resected hepatocellular carcinomas, 35 corresponding surrounding liver tissues and 10 normal liver samples were used for the study. In 15 of 35 cases the tumor developed on the basis of cirrhosis. Matrilin-2 protein expression was detected in normal liver around bile ducts, portal blood vessels, while sinusoids were negative by immunohistochemistry. Cirrhotic surrounding tissue showed intensive matrilin-2 staining along the sinusoids. Tumorous neovasculature was found strongly positive by immunohistochemistry. No differences, however, were detected by morphometry regarding the amount of protein expression based on the grade of hepatocellular carcinomas. Real-time RT-PCR did not show significant differences in matrilin-2 mRNA expression between normal, cirrhotic and tumor samples. This suggests posttranslational modification of matrilin-2 manifesting in altered distribution in liver fibrosis. Our data indicate that matrilin-2 is a novel basement membrane component in the liver, which is synthetised during sinusoidal "capillarization" in cirrhosis and in hepatocellular carcinoma. This is the first report to describe the expression and distribution of matrilin-2 in human normal and cirrhotic liver as well as in hepatocellular carcinoma.

AB - The recently described matrilin protein family is part of the extracellular matrix, their pathophysiological role as well as distribution in liver diseases, however, have not yet been studied. Considering that matrilins have been found to play role in cell growth and tissue remodeling, their possible involvement in carcinogenesis has been raised. The main objective of this study was to investigate the changes in matrilin-2 expression which is one of the main components of basement membranes. Thirty-five cases of surgically resected hepatocellular carcinomas, 35 corresponding surrounding liver tissues and 10 normal liver samples were used for the study. In 15 of 35 cases the tumor developed on the basis of cirrhosis. Matrilin-2 protein expression was detected in normal liver around bile ducts, portal blood vessels, while sinusoids were negative by immunohistochemistry. Cirrhotic surrounding tissue showed intensive matrilin-2 staining along the sinusoids. Tumorous neovasculature was found strongly positive by immunohistochemistry. No differences, however, were detected by morphometry regarding the amount of protein expression based on the grade of hepatocellular carcinomas. Real-time RT-PCR did not show significant differences in matrilin-2 mRNA expression between normal, cirrhotic and tumor samples. This suggests posttranslational modification of matrilin-2 manifesting in altered distribution in liver fibrosis. Our data indicate that matrilin-2 is a novel basement membrane component in the liver, which is synthetised during sinusoidal "capillarization" in cirrhosis and in hepatocellular carcinoma. This is the first report to describe the expression and distribution of matrilin-2 in human normal and cirrhotic liver as well as in hepatocellular carcinoma.

KW - Basement membrane

KW - Cirrhosis

KW - Extracellular matrix

KW - Hepatocellular carcinoma

KW - Matrilin-2

UR - http://www.scopus.com/inward/record.url?scp=49349109677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49349109677&partnerID=8YFLogxK

U2 - 10.1007/s12253-008-9005-4

DO - 10.1007/s12253-008-9005-4

M3 - Article

C2 - 18386166

AN - SCOPUS:49349109677

VL - 14

SP - 15

EP - 22

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

IS - 1

ER -